BMJ 1997;315:1502-1504 (6 December)
Papers
Case-control study of oral contraceptives and risk of thromboembolic stroke: results from international study on oral contraceptives and health of young women
Lothar A J Heinemann,
director
and
professor,a
Michael A Lewis,
director,b
Margaret Thorogood,
reader,c
Walter O Spitzer,
professor
emeritus,d
Irene Guggenmoos-Holzmann,
director and professor,e
Rudolf Bruppacher,
professor fa ZEG-Centre for Epidemiology and Health Research Berlin, D-16341 Zepernick, Germany,
b EPES Epidemiology Pharmaco-epidemiology and Systems Research, D-12165 Berlin, Germany,
c Health Promotion Sciences Unit, London School of Hygiene and Tropical Medicine, London WC1E 7HT,
d Department of Epidemiology and Biostatistics, McGill University Montreal, QC, Canada H3A 1A2,
e Institute of Medical Statistics, Epidemiology and Informatics, Free University Berlin, D-12200 Berlin, Germany,
f University Basle, CH-4310 Rheinfelden, Switzerland,
Correspondence to: Professor Heinemann
Objective: To determine the influence of oral
contraceptives (particularly those containing modern progestins) on the risk for ischaemic stroke
in
women aged 16-44 years.
Design: Matched case-control study.
Setting: 16 centres in the United Kingdom,
Germany,
France, Switzerland, and Austria.
Subjects: Cases were 220 women aged 16-44
who had an incident ischaemic stroke. Controls were 775 women ( at least one hospital and one
community control per case) unaffected by stroke who were matched with the corresponding case
for 5 year age band and for hospital or community setting. Information on exposure and
confounding
variables were collected in a face to face interview.
Main outcome measures: Odds ratios derived with
stratified analyses and unconditional logistic regression to adjust for potential
confounding.
Results: Adjusted odds ratios (95%
confidence
intervals) for ischaemic stroke (unmatched analysis) were 4.4 (2.0 to 9.9), 3.4 ( 2.1 to 5.5), and
3.9
(2.3 to 6.6) for current use of first, second, and third generation oral contraceptives, respectively.
The risk ratio for third versus second generation was 1.1 (0.7 to 2.0) and was similar in the
United
Kingdom and other European countries. The risk estimates were lower if blood pressure was
checked before prescription.
Conclusion: Although there is a small relative risk
of
occlusive stroke for women of reproductive age who currently use oral contraceptives, the
attributable risk is very small because the incidence in this age range is very low. There is no
difference between the risk of oral contraceptives of the third and second generation; only first
generation oral contraceptives seem to be associated with a higher risk. This small increase in
risk
may be further reduced by efforts to control cardiovascular risk factors, particularly high blood
pressure.
|
Key messages
- This study shows a slightly increased relative risk of thromboembolic stroke in women
currently using oral contraceptives compared with women not using them. The high dose
oestrogen
pills carry a higher risk than the low dose formulations, irrespective of the type of
progestin
- The absolute risk of occlusive stroke for women who currently use modern oral
contraceptives is very smallthat is, the incidence in this age range is very low and not
different between second and third generation oral contraceptives
- This small increase in risk can be controlled by avoiding prescription of oral
contraceptives
to women who have evidence of cardiovascular disease, in particular high blood pressure
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Article
-
Drug use in children: cohort study in three European countries
- Miriam C J M Sturkenboom, Katia M C Verhamme, Alfredo Nicolosi, Macey L Murray, Antje Neubert, Daan Caudri, Gino Picelli, Elif Fatma Sen, Carlo Giaquinto, Luigi Cantarutti, Paola Baiardi, Maria-Grazia Felisi, Adriana Ceci, Ian C K Wong on behalf of the TEDDY European Network of Excellence
BMJ 2008 337: a2245.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Sturkenboom, M. C J M, Verhamme, K. M C, Nicolosi, A., Murray, M. L, Neubert, A., Caudri, D., Picelli, G., Sen, E. F., Giaquinto, C., Cantarutti, L., Baiardi, P., Felisi, M.-G., Ceci, A., Wong, I. C K, on behalf of the TEDDY European Network of Excelle,
(2008). Drug use in children: cohort study in three European countries. BMJ
337: a2245-a2245
[Abstract]
[Full text]
-
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L.
(2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Circulation
113: e873-e923
[Abstract]
[Full text]
-
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L.
(2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Stroke
37: 1583-1633
[Abstract]
[Full text]
-
Chan, W.-S., Ray, J., Wai, E. K., Ginsburg, S., Hannah, M. E., Corey, P. N., Ginsberg, J. S.
(2004). Risk of Stroke in Women Exposed to Low-Dose Oral Contraceptives: A Critical Evaluation of the Evidence. Arch Intern Med
164: 741-747
[Abstract]
[Full text]
-
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W.M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., Rosendaal, F. R.
(2001). Oral Contraceptives and the Risk of Venous Thrombosis. NEJM
344: 1527-1535
[Full text]
-
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J., Members,
(2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Circulation
103: 163-182
[Full text]
-
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J.
(2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Stroke
32: 280-299
[Full text]
-
Mira, Y., Aznar, J., Estelles, A., Vaya, A., Villa, P., Ferrando, F.
(2000). State-of-the-Art Review : Congenital and Acquired Thrombotic Risk Factors in Women Using Oral Contraceptives: Clinical Aspects. CLIN APPL THROMB HEMOST
6: 162-168
[Abstract]
-
, T. E. C. W. G.
(2000). Screening before and during the use of oral contraceptives and hormone replacement therapy. Hum Reprod
15: 485-492
[Abstract]
[Full text]
-
Lewis, M. A., MacRae, K. D., Kuhl-Habich1, D., Bruppacher, R., Heinemann, L. A.J., Spitzer, W. O.
(1999). The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod
14: 1493-1499
[Abstract]
[Full text]
-
(1998). More on OCs and Thromboembolic Stroke. JWatch Women's Health
1998: 8-8
[Full text]
-
(1998). ORAL CONTRACEPTIVES AND RISK FOR ISCHEMIC STROKE. JWatch General
1998: 7-7
[Full text]